, Gene therapy comes of age, vol.359, p.4672, 2018.
Hemophilia B gene therapy with a high-specific-activity factor IX variant, N. Engl. J. Med, vol.377, pp.2215-2227, 2017. ,
Long-term safety and efficacy of factor IX gene therapy in hemophilia B, N. Engl. J. Med, vol.371, 1994. ,
AAV5-factor VIII gene transfer in severe hemophilia A, N. Engl. J. Med, vol.377, pp.2519-2530, 2017. ,
Adeno-associated viral vectors for the treatment of hemophilia, Hum. Mol. Genet, vol.25, pp.36-41, 2016. ,
Gene therapy returns to centre stage, Nature, vol.526, pp.351-360, 2015. ,
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: An ad-hoc analysis of a non-randomised, open-label, Lancet, vol.388, pp.476-487, 2016. ,
Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice, Blood, vol.120, pp.4517-4520, 2012. ,
Liver-directed lentiviral gene therapy in a dog model of hemophilia B, Sci. Transl. Med, vol.7, pp.277-228, 2015. ,
Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer, Nat. Med, vol.12, pp.585-591, 2006. ,
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice, Blood, vol.110, pp.4144-4152, 2007. ,
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver, Mol. Ther, vol.3, pp.28-35, 2001. ,
Phagocytosis: An immunobiologic process, Immunity, vol.44, pp.463-475, 2016. ,
The liver as an immunological organ, Hepatology, vol.43, pp.54-62, 2006. ,
CD47-signal regulatory protein ? (SIRP?) regulates Fc? and complement receptor-mediated phagocytosis, J. Exp. Med, vol.193, pp.855-862, 2001. ,
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells, Nat. Immunol, vol.8, pp.1313-1323, 2007. ,
A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade, Mol. Ther, vol.20, pp.2257-2267, 2012. ,
Role of CD47 as a marker of self on red blood cells, Science, vol.288, pp.2051-2054, 2000. ,
CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells, Cell, vol.138, pp.286-299, 2009. ,
Minimal "self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles, Science, vol.339, pp.971-975, 2013. ,
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis, Nature, vol.536, pp.86-90, 2016. ,
SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx, Nature, vol.474, pp.654-657, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00616451
Genetic engineering of hematopoiesis for targeted IFN-? delivery inhibits breast cancer progression, Sci. Transl. Med, vol.6, pp.217-213, 2014. ,
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy, EMBO Mol. Med, vol.9, pp.1558-1573, 2017. ,
Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo, J. Virol, vol.69, pp.6445-6456, 1995. ,
Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell, Virology, vol.360, pp.286-293, 2007. ,
, Immunosurveillance of the liver by intravascular effector CD8 + T cells, vol.161, pp.486-500, 2015.
Intravital microscopy analysis of hepatic T cell dynamics, Methods Mol. Biol, vol.1514, pp.49-61, 2017. ,
Restriction of retroviral replication by APOBEC3G/F and TRIM5?, Trends Microbiol, vol.16, pp.612-619, 2008. ,
Stepping toward a macaque model of HIV-1 induced AIDS, Viruses, vol.6, pp.3643-3651, 2014. ,
X-linked thrombophilia with a mutant factor IX (factor IX Padua), N. Engl. J. Med, vol.361, pp.1671-1675, 2009. ,
Evaluation of the toxicology, pharmacokinetics, and local tolerance of recombinant factor IX Fc fusion protein in animals, Thromb. Res, vol.136, pp.371-378, 2015. ,
Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques, Blood, vol.100, pp.1662-1669, 2002. ,
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection, Blood, vol.117, pp.5332-5339, 2011. ,
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy, Science, vol.341, p.1233158, 2013. ,
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome, Science, vol.341, p.1233151, 2013. ,
Innate immune interferon responses to human immunodeficiency virus-1 infection, Rev. Med. Virol, vol.22, pp.257-266, 2012. ,
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.7306-7311, 2013. ,
In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance, Blood, vol.114, pp.5152-5161, 2009. ,
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state, Nat. Biotechnol, vol.25, pp.1457-1467, 2007. ,
Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors ,
, Mol. Ther. Methods Clin. Dev, vol.3, p.16080, 2016.
The role of liver sinusoidal cells in hepatocyte-directed gene transfer, Am. J. Pathol, vol.176, pp.14-21, 2010. ,
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver, Blood, vol.110, pp.2334-2341, 2007. ,
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy, J. Clin. Invest, vol.119, pp.964-975, 2009. ,
A factor IX-deficient mouse model for hemophilia B gene therapy, Proc. Natl. Acad. Sci. U.S.A, vol.94, pp.11563-11566, 1997. ,
Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing, Cell, vol.167, pp.219-232, 2016. ,
Site-specific integration and tailoring of cassette design for sustainable gene transfer, Nat. Methods, vol.8, pp.861-869, 2011. ,
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk, Hepatology, vol.53, pp.1696-1707, 2011. ,
Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites, Genome Med, vol.6, p.46, 2014. ,
The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones, Blood, vol.117, pp.3113-3122, 2011. ,
VISPA2: A scalable pipeline for high-throughput identification and annotation of vector integration sites, BMC Bioinformatics, vol.18, p.520, 2017. ,
Analyzing the number of common integration sites of viral vectors-New methods and computer programs, PLOS ONE, vol.6, p.24247, 2011. ,
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo, Mol. Ther, vol.22, pp.774-785, 2014. ,
,
, , p.7325
, Sci Transl Med that LV-mediated gene therapy might be an effective strategy for treating hemophilia and possibly other disorders. administration in monkeys, the LVs showed high transduction efficacy without signs of toxicity. The results suggest phagocytosis by increasing the content of the phagocytosis inhibitor CD47 on their surface. Upon intravenous . developed a shielded LV able to escape et al efficacy possibly due to fast clearance by phagocytes. Now, Milani vectors (LVs) has been explored as possible alternative; however, preclinical data reported low transduction hemophilia. However, AAVs have limitations hindering their efficacy in a subgroup of patients. The use of lentiviral Gene therapy using adeno
, CONTENT RELATED
, This article cites 53 articles, 17 of which you can access for free